Direct Cellular Effects of Blood Coagulation Proteases

凝血蛋白酶的直接细胞效应

基本信息

项目摘要

The major scientific goal of this Pathway to Independence (K99/ROO) Career Development Award application is to understand the molecular pathophysiology of thrombotic and inflammatory disorders by studying novel mechanisms for cytoprotective actions of vitamin K-dependent coagulation proteases. This application focuses initially on the role of membrane receptors in the regulation of the cellular protein C pathway and later on the exploration of novel mechanisms for cytoprotective activities of coagulation proteases. The major career development goal of the applicant is to expand his technical and academic experience required for a successful transition into an independent investigator. These studies will provide the opportunity and solid basis to apply successfully for future independent NIH R01 funding focused on the molecular mechanistic studies centered on the crossroads of coagulation and inflammation. Novel hypotheses on the functional proteomics of cytoprotective actions by blood coagulation proteases will be tested using biochemical and cellular biology methods. The clinical and therapeutic implications of the proposed studies are clear from the large clinical trials, where activated protein C (ARC), but not other anticoagulants reduced mortality in severe sepsis patients and implied that the unique combination of APC's anticoagulant activity and direct activity on cells is the basis for APC's success. My published work and unpublished preliminary data lead directly to the proposed studies and provide strong support for my hypotheses. In testing these hypotheses, I propose: 1) To characterize the formation of endothelial cell membrane receptor complexes between thrombomodulin, endothelial protein C receptor and protease activated receptor-1 required for APC generation and APC's direct effects on cells; 2) To clarify the potential beneficial and detrimental functional properties of platelet factor 4 for APC generation and APC's direct effects on cells; 3) To identify novel themes and mechanisms for APC and fVlla cytoprotective actions on cells by exploration of the similarities and differences between APC and fVlla anti-apoptotic activities; and 4) To establish whether meizothrombin has anti-apoptotic activity, as predicted, and if this activity requires cofactor-dependent and PAR-dependent mechanisms. If the proposed studies are successful, they will increase our knowledge and may lead to improved treatment of a variety of disorders in which thrombosis, apoptosis and inflammation contribute to pathogenesis.
独立之路(K99/ROO)职业发展奖申请的主要科学目标 是通过研究新的机制来了解血栓和炎症性疾病的分子病理生理学 维生素 K 依赖性凝血蛋白酶的细胞保护作用机制。这个应用程序 最初关注膜受体在细胞蛋白 C 途径调节中的作用, 随后探索了凝血蛋白酶细胞保护活性的新机制。主要 申请人的职业发展目标是扩大其所需的技术和学术经验 成功转型为独立调查员。这些研究将提供机会和坚实的 为成功申请未来专注于分子机制的独立 NIH R01 资金奠定基础 研究集中在凝血和炎症的十字路口。关于泛函的新假设 凝血蛋白酶的细胞保护作用的蛋白质组学将使用生化和 细胞生物学方法。从以下数据中可以清楚地看出拟议研究的临床和治疗意义 大型临床试验,其中活性蛋白 C (ARC) 而不是其他抗凝剂可降低重症患者的死亡率 败血症患者并暗示 APC 的抗凝活性和直接活性的独特组合 细胞是APC成功的基础。我已发表的作品和未发表的初步数据直接导致 提出的研究并为我的假设提供了强有力的支持。在检验这些假设时,我建议:1) 为了表征血栓调节蛋白之间内皮细胞膜受体复合物的形成, APC 生成和 APC 所需的内皮蛋白 C 受体和蛋白酶激活受体 1 对细胞的直接影响; 2) 阐明血小板潜在的有益和有害的功能特性 APC 生成的因子 4 以及 APC 对细胞的直接影响; 3)确定新的主题和机制 通过探索 APC 和 fVIIa 对细胞的异同 APC 和 fVIIa 抗凋亡活性; 4) 确定酶促凝血酶是否具有抗细胞凋亡作用 活性,如预测的那样,以及该活性是否需要辅因子依赖性和 PAR 依赖性机制。如果 拟议的研究是成功的,它们将增加我们的知识,并可能导致改善治疗 血栓形成、细胞凋亡和炎症参与发病机制的多种疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Laurent Olivier Mosnier其他文献

Laurent Olivier Mosnier的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Laurent Olivier Mosnier', 18)}}的其他基金

Novel functions of Thrombin Activatable Fibrinolysis Inhibitor (TAFI)
凝血酶激活纤溶抑制剂(TAFI)的新功能
  • 批准号:
    10378545
  • 财政年份:
    2020
  • 资助金额:
    $ 24.9万
  • 项目类别:
Novel functions of Thrombin Activatable Fibrinolysis Inhibitor (TAFI)
凝血酶激活纤溶抑制剂(TAFI)的新功能
  • 批准号:
    10606626
  • 财政年份:
    2020
  • 资助金额:
    $ 24.9万
  • 项目类别:
Structure-function of cytoprotective coagulation proteases and their receptors
细胞保护性凝血蛋白酶及其受体的结构-功能
  • 批准号:
    8389869
  • 财政年份:
    2010
  • 资助金额:
    $ 24.9万
  • 项目类别:
Structure-function of cytoprotective coagulation proteases and their receptors
细胞保护性凝血蛋白酶及其受体的结构-功能
  • 批准号:
    10599854
  • 财政年份:
    2010
  • 资助金额:
    $ 24.9万
  • 项目类别:
Structure-function of cytoprotective coagulation proteases and their receptors
细胞保护性凝血蛋白酶及其受体的结构-功能
  • 批准号:
    8050509
  • 财政年份:
    2010
  • 资助金额:
    $ 24.9万
  • 项目类别:
Structure-function of cytoprotective coagulation proteases and their receptors
细胞保护性凝血蛋白酶及其受体的结构-功能
  • 批准号:
    8197736
  • 财政年份:
    2010
  • 资助金额:
    $ 24.9万
  • 项目类别:
Structure-function of cytoprotective coagulation proteases and their receptors
细胞保护性凝血蛋白酶及其受体的结构-功能
  • 批准号:
    10221413
  • 财政年份:
    2010
  • 资助金额:
    $ 24.9万
  • 项目类别:
Structure-function of cytoprotective coagulation proteases and their receptors
细胞保护性凝血蛋白酶及其受体的结构-功能
  • 批准号:
    8585871
  • 财政年份:
    2010
  • 资助金额:
    $ 24.9万
  • 项目类别:
Structure-function of cytoprotective coagulation proteases and their receptors
细胞保护性凝血蛋白酶及其受体的结构-功能
  • 批准号:
    10372205
  • 财政年份:
    2010
  • 资助金额:
    $ 24.9万
  • 项目类别:
Direct Cellular Effects of Blood Coagulation Proteases
凝血蛋白酶的直接细胞效应
  • 批准号:
    7545924
  • 财政年份:
    2006
  • 资助金额:
    $ 24.9万
  • 项目类别:

相似海外基金

NSF-BSF: Towards a Molecular Understanding of Dynamic Active Sites in Advanced Alkaline Water Oxidation Catalysts
NSF-BSF:高级碱性水氧化催化剂动态活性位点的分子理解
  • 批准号:
    2400195
  • 财政年份:
    2024
  • 资助金额:
    $ 24.9万
  • 项目类别:
    Standard Grant
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
  • 批准号:
    2334970
  • 财政年份:
    2024
  • 资助金额:
    $ 24.9万
  • 项目类别:
    Standard Grant
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
  • 批准号:
    2334969
  • 财政年份:
    2024
  • 资助金额:
    $ 24.9万
  • 项目类别:
    Standard Grant
Mechanochemical synthesis of nanocarbon and design of active sites for oxygen reducton/evolution reactions
纳米碳的机械化学合成和氧还原/演化反应活性位点的设计
  • 批准号:
    23K04919
  • 财政年份:
    2023
  • 资助金额:
    $ 24.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Creation of porous inorganic frameworks with controlled structure of metal active sites by the building block method.
通过积木法创建具有金属活性位点受控结构的多孔无机框架。
  • 批准号:
    22KJ2957
  • 财政年份:
    2023
  • 资助金额:
    $ 24.9万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Catalysis of Juxaposed Active Sites Created in Nanospaces and Their Applications
纳米空间中并置活性位点的催化及其应用
  • 批准号:
    23K04494
  • 财政年份:
    2023
  • 资助金额:
    $ 24.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Generation of carbon active sites by modifying the oxygen containing functional groups and structures of carbons for utilizing to various catalytic reactions.
通过修饰碳的含氧官能团和结构来产生碳活性位点,用于各种催化反应。
  • 批准号:
    23K13831
  • 财政年份:
    2023
  • 资助金额:
    $ 24.9万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
CAREER: CAS: Understanding the Chemistry of Palladium and Silyl Compounds to Design Catalyst Active Sites
职业:CAS:了解钯和甲硅烷基化合物的化学性质以设计催化剂活性位点
  • 批准号:
    2238379
  • 财政年份:
    2023
  • 资助金额:
    $ 24.9万
  • 项目类别:
    Continuing Grant
CAS: Collaborative Research: Tailoring the Distribution of Transient vs. Dynamic Active Sites in Solid-Acid Catalysts and Their Impacts on Chemical Conversions
CAS:合作研究:定制固体酸催化剂中瞬时活性位点与动态活性位点的分布及其对化学转化的影响
  • 批准号:
    2154399
  • 财政年份:
    2022
  • 资助金额:
    $ 24.9万
  • 项目类别:
    Standard Grant
Engineering of Active Sites in Heterogeneous Catalysts for Sustainable Chemical and Fuel Production.
用于可持续化学和燃料生产的多相催化剂活性位点工程。
  • 批准号:
    RGPIN-2019-06633
  • 财政年份:
    2022
  • 资助金额:
    $ 24.9万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了